These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23520767)

  • 41. Insider access: pepducin symposium explores a new approach to GPCR modulation.
    Miller J; Agarwal A; Devi LA; Fontanini K; Hamilton JA; Pin JP; Shields DC; Spek CA; Sakmar TP; Kuliopulos A; Hunt SW
    Ann N Y Acad Sci; 2009 Nov; 1180 Suppl 1():E1-12. PubMed ID: 19925639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. G protein coupled receptors as allosteric proteins and the role of allosteric modulators.
    Kenakin T
    J Recept Signal Transduct Res; 2010 Oct; 30(5):313-21. PubMed ID: 20858023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy Selectivity.
    Zhang R; Kavana M
    Sci Rep; 2016 Apr; 6():25158. PubMed ID: 27116909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In search of negative allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2009 Jan; 14(1-2):41-9. PubMed ID: 18973826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancer and competitive allosteric modulation model for G-protein-coupled receptors.
    Pietra D; Borghini A; Breschi MC; Bianucci AM
    J Theor Biol; 2010 Dec; 267(4):663-75. PubMed ID: 20800599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bridging the gap: bitopic ligands of G-protein-coupled receptors.
    Lane JR; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2013 Jan; 34(1):59-66. PubMed ID: 23177916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternative drug discovery approaches for orphan GPCRs.
    Levoye A; Jockers R
    Drug Discov Today; 2008 Jan; 13(1-2):52-8. PubMed ID: 18190864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are GPCRs still a source of new targets?
    Garland SL
    J Biomol Screen; 2013 Oct; 18(9):947-66. PubMed ID: 23945874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in structure based drug design for G protein-coupled receptors.
    Congreve M; Langmead CJ; Mason JS; Marshall FH
    J Med Chem; 2011 Jul; 54(13):4283-311. PubMed ID: 21615150
    [No Abstract]   [Full Text] [Related]  

  • 52. [G-protein-coupled receptors: general features and activation mechanisms].
    Bockaert J
    Bull Acad Natl Med; 2012 Dec; 196(9):1765-75. PubMed ID: 24552100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms.
    Agnati LF; Guidolin D; Leo G; Guescini M; Pizzi M; Stocchi V; Spano PF; Ghidoni R; Ciruela F; Genedani S; Fuxe K
    J Recept Signal Transduct Res; 2011 Oct; 31(5):315-31. PubMed ID: 21929287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New technologies enabling the industrialization of allosteric modulator discovery.
    Lütjens R; Perry B; Schelshorn D; Rocher JP
    Drug Discov Today Technol; 2013; 10(2):e253-60. PubMed ID: 24050276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allosteric modulation of G-protein coupled receptors.
    Jensen AA; Spalding TA
    Eur J Pharm Sci; 2004 Mar; 21(4):407-20. PubMed ID: 14998571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel G protein-coupled receptors as pain targets.
    Ahmad S; Dray A
    Curr Opin Investig Drugs; 2004 Jan; 5(1):67-70. PubMed ID: 14983976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.
    Hutchings CJ; Koglin M; Olson WC; Marshall FH
    Nat Rev Drug Discov; 2017 Sep; 16(9):787-810. PubMed ID: 28706220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New insights into GPCR function: implications for HTS.
    Eglen RM; Reisine T
    Methods Mol Biol; 2009; 552():1-13. PubMed ID: 19513638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allosteric approaches to GPCR drug discovery.
    Lane JR; IJzerman AP
    Drug Discov Today Technol; 2013; 10(2):e219-21. PubMed ID: 24050271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.